(Q84716271)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19826402%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

review article

1 reference

title

Pediatric multiple sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19826402%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

2

Tanuja Chitnis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19826402%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

author name string

E Ann Yeh

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19826402%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Lauren Krupp

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19826402%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Jayne Ness

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19826402%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Dorothée Chabas

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19826402%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Nancy Kuntz

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19826402%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Emmanuelle Waubant

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19826402%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

US Network of Pediatric Multiple Sclerosis Centers of Excellence

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19826402%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

publication date

13 October 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19826402%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

published in

Nature Reviews Neurology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19826402%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19826402%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19826402%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

621-631

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19826402%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrneurol.2009.158

9 February 2020

exact match

0 references

cites work

Consensus definitions proposed for pediatric multiple sclerosis and related disorders

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Natural history of multiple sclerosis with childhood onset.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Demographics of pediatric-onset multiple sclerosis in an MS center population from the Northeastern United States.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Multiple sclerosis in childhood: clinical features of 149 cases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Early onset multiple sclerosis: a longitudinal study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Incidence of acquired demyelination of the CNS in Canadian children

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Multiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Pediatric-onset multiple sclerosis in African-American black and European-origin white patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Age at onset of multiple sclerosis may be influenced by place of residence during childhood rather than ancestry

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Abnormal T-cell reactivities in childhood inflammatory demyelinating disease and type 1 diabetes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Myelin basic protein and myelin oligodendrocyte glycoprotein T-cell repertoire in childhood and juvenile multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Tau, phospho-tau, and S-100B in the cerebrospinal fluid of children with multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Clinically observed chickenpox and the risk of childhood-onset multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Hepatitis B vaccine and risk of relapse after a first childhood episode of CNS inflammatory demyelination.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Parental smoking at home and the risk of childhood-onset multiple sclerosis in children

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Multiple sclerosis and acute disseminated encephalomyelitis diagnosed in children after long-term follow-up: comparison of presenting features

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Early relapse risk after a first CNS inflammatory demyelination episode: examining international consensus definitions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

CNS aquaporin-4 autoimmunity in children

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Vanishing MS T2-bright lesions before puberty: a distinct MRI phenotype?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

MRI prognostic factors for relapse after acute CNS inflammatory demyelination in childhood

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Multiple sclerosis in childhood: clinical profile in 125 patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Multiple sclerosis in children: report of clinical and paraclinical features of 19 cases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Early onset MS under the age of 16: clinical and paraclinical features

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

A long perspective on childhood multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Pediatric multiple sclerosis report of 14 cases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Multiple sclerosis in childhood: report of 16 cases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Juvenile multiple sclerosis: clinical features and prognostic characteristics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Definite and suspected multiple sclerosis in children: long-term follow-up and magnetic resonance imaging findings.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Prospective study of multiple sclerosis with early onset

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

The natural history of early onset multiple sclerosis: comparison of data from Moscow and Vancouver

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Course and prognosis in early-onset MS: comparison with adult-onset forms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Multiple sclerosis vs acute disseminated encephalomyelitis in childhood

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Childhood and juvenile onset multiple sclerosis: clinical and paraclinical features.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

First episode of acute CNS inflammatory demyelination in childhood: prognostic factors for multiple sclerosis and disability.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Clinical course and prognosis of 27 patients with childhood onset multiple sclerosis in Japan.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Clinical characteristics and long term prognosis in early onset multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Paediatric multiple sclerosis and acute disseminated encephalomyelitis in Germany: results of a nationwide survey.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Paediatric multiple sclerosis: the experience of the German Centre for Multiple Sclerosis in Childhood and Adolescence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Clinical and diagnostic aspects of multiple sclerosis and acute monophasic encephalomyelitis in pediatric patients: a single centre prospective study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

CSF characteristics in early-onset multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Pediatric multiple sclerosis: detection of clinically silent lesions by multimodal evoked potentials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Optical coherence tomography in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Retinal nerve fiber thickness in inflammatory demyelinating diseases of childhood onset.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

MRI criteria for multiple sclerosis: Evaluation in a pediatric cohort

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Pediatric multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Prognostic factors after a first attack of inflammatory CNS demyelination in children

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Role of MRI in the differentiation of ADEM from MS in children

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Acute disseminated encephalomyelitis in childhood: epidemiologic, clinical and laboratory features

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Acute disseminated encephalomyelitis cohort study: prognostic factors for relapse.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Very early onset multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Cognitive impairment in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Cognitive impairment in early-onset multiple sclerosis. Pattern, predictors, and impact on everyday life in a 4-year follow-up

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Cognitive functioning in children and adolescents with multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

The cognitive burden of multiple sclerosis in children

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Longitudinal neuropsychological assessment in pediatric multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Cognitive and psychosocial features of childhood and juvenile MS.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

PCR for bacterial 16S ribosomal DNA in multiple sclerosis cerebrospinal fluid

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Treatment of early-onset multiple sclerosis with intramuscular interferonbeta-1a: long-term results.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Effectiveness of early beta interferon on the first attack after confirmed multiple sclerosis: a comparative cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Interferon-beta treatment in patients with childhood-onset multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Safety and tolerability of interferon beta-1b in pediatric multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Treatment of early onset multiple sclerosis with subcutaneous interferon beta-1a

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Interferon beta-1a treatment in childhood and juvenile-onset multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Sustained immunological effects of Glatiramer acetate in patients with multiple sclerosis treated for over 6 years

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Glatiramer acetate treatment in patients with childhood and juvenile onset multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Switching algorithms: from one immunomodulatory agent to another

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Identifying and treating patients with suboptimal responses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Cyclophosphamide therapy in pediatric multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Natalizumab treatment in pediatric multiple sclerosis: a case report

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Natalizumab use in pediatric multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.158

Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group

31 March 2020

1 reference

12 December 2020

Multiple sclerosis in childhood: Report of 15 cases

1 reference

12 December 2020

Childhood-onset multiple sclerosis: report of 82 patients from Isfahan, Iran.

1 reference

12 December 2020

High seroprevalence of Epstein-Barr virus in children with multiple sclerosis

1 reference

12 December 2020

Multiple sclerosis in children; a clinical study of 40 cases with onset in childhood

1 reference

12 December 2020

[The use of beta-interferon-1b in children and adolescents with multiple sclerosis]

1 reference

12 December 2020